New 20-year data show a survival rate of 90% with few repeat surgeries after this complex operation that can only be ...

have coexisting aortic regurgitation (AR). However, few data exist regarding its clinical significance and prognostic value. The aim of this study was to examine the effect of concomitant significant ...

Background Cardiogenic shock (CS) induced by severe aortic stenosis (AS) is a life-threatening condition with high mortality.

GlobalData analysts anticipate FDA approval for the JenaValve Trilogy TAVR device designed to treat aortic regurgitation (AR) ...

Young patients who have undergone the Ross procedure for aortic valve disease have shown excellent long-term survival, the ...

med.ulaval.ca To be aware of the prevalence, pathophysiology and outcomes of mixed aortic valve disease (MAVD), which refers to combined aortic stenosis and aortic regurgitation. To assess the ...

"As an aside, the Ross procedure, which is my preference in this age group, is the only aortic valve replacement procedure ...

Proposed changes to appeal period for technology appraisal and highly specialised technologies appeals Methods / process manual consultation NICE process and methods 16 February 2025 Spesolimab for ...

A.L. (M.G.H. 1283255), a 30-year-old Negro mother of 7, entered the Massachusetts General Hospital because of increasingly severe dyspnea ... There was free aortic regurgitation because of ...

device designed for aortic regurgitation (AR), by late 2025. This approval will mark a significant step forward, expanding TAVR’s treatment indications to include AR — a condition previously ...